Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 37 (3) , 255-269
- https://doi.org/10.1016/0167-0115(92)90619-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro‐entero‐pancreatic hormones in man Feedback control of cholecystokinin and gastrin secretionEuropean Journal of Clinical Investigation, 1991
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.Journal of Clinical Investigation, 1990
- Measurement of tissue cholecystokinin (CCK) concentrations by bioassay and specific radioimmunoassay: characterization of the bioactivity of CCK‐58 before and after tryptic cleavageEuropean Journal of Clinical Investigation, 1990
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.Journal of Clinical Investigation, 1989
- Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK.Gut, 1989
- Plasma cholecystokinin-octapeptide like immunoreactivity in patients with hepatic cirrhosisLife Sciences, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.Journal of Clinical Investigation, 1985
- Measurement of cholecystokinin octapeptide using a new specific radioimmunoassayPeptides, 1985
- Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassaysDigestive Diseases and Sciences, 1984